<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-1503474135064942707</atom:id><lastBuildDate>Fri, 13 Nov 2009 19:59:31 +0000</lastBuildDate><title>ePharma Summit</title><description>ePHARMA SUMMIT has its finger on the pulse of the industry as it covers the new dynamics of media engagement as we consider emerging pharmaceutical marketing/emarketing uses of web 2.0 and social media.</description><link>http://epharmasummit.blogspot.com/</link><managingEditor>noreply@blogger.com (Yemil)</managingEditor><generator>Blogger</generator><openSearch:totalResults>290</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><creativeCommons:license>http://creativecommons.org/licenses/by/2.0/</creativeCommons:license><image><link>http://creativecommons.org/licenses/by/2.0/</link><url>http://creativecommons.org/images/public/somerights20.gif</url><title>Some Rights Reserved</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/ePharmaSummit" type="application/rss+xml" /><feedburner:emailServiceId>ePharmaSummit</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-1892574437095786548</guid><pubDate>Fri, 13 Nov 2009 18:59:00 +0000</pubDate><atom:updated>2009-11-13T14:50:51.392-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">fda warnings</category><category domain="http://www.blogger.com/atom/ns#">Internet marketing regulations</category><category domain="http://www.blogger.com/atom/ns#">FDA Hearings</category><category domain="http://www.blogger.com/atom/ns#">FDA regulations</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>FDA Hearings Underway in DC</title><atom:summary>Yesterday, the FDA began their two day hearing discussing how Pharma companies can interact and market their products on the internet.  The hearing is to determine whether or not the FDA needs to incorporate themselves more into regulating how marketing is done on the internet.  Many drug companies are saying there are many websites that currently have information about about drugs on their </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/v-0SWJUeKoQ/fda-hearings-underway-in-dc.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/v-0SWJUeKoQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/11/fda-hearings-underway-in-dc.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-7096136181483145371</guid><pubDate>Thu, 12 Nov 2009 15:12:00 +0000</pubDate><atom:updated>2009-11-12T10:16:52.168-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FDA online marketing</category><category domain="http://www.blogger.com/atom/ns#">epharma FDA</category><category domain="http://www.blogger.com/atom/ns#">epharma updates</category><category domain="http://www.blogger.com/atom/ns#">epharma news</category><category domain="http://www.blogger.com/atom/ns#">epharma industry</category><title>Drug industry presses FDA to allow more online ads</title><atom:summary>The Associated Press writes that the Food and Drug Administration will convene a two-day meeting beginning Thursday to hear the drug industry's position on Internet marketing. The agency has agreed to consider developing rules for online advertising after companies complained that the current guidelines for traditional media — which require a detailed list of possible side effects — have left </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/LXdfJcuGyZs/drug-industry-presses-fda-to-allow-more.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/LXdfJcuGyZs" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/11/drug-industry-presses-fda-to-allow-more.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-3120776021391646509</guid><pubDate>Wed, 11 Nov 2009 20:10:00 +0000</pubDate><atom:updated>2009-11-11T15:19:43.718-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Medicare</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">text</category><category domain="http://www.blogger.com/atom/ns#">2010 ePharma summit</category><category domain="http://www.blogger.com/atom/ns#">IntelReader</category><category domain="http://www.blogger.com/atom/ns#">Intel</category><title>Intel Releases its Own "Text" Reader for the Health Care Market</title><atom:summary>This post in the NY Times highlights a new handheld device unveiled by Intel called the IntelReader that helps people who struggle to read standard texts because of certain medical conditions. The reader is able to scan books and other printed texts into a digital form, and then read it aloud to its users.The device, which is priced at 1$,500, is far less than any other text-to-speech devices </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/Z0kjWwSLmKk/intel-releases-its-own-text-reader-for.html</link><author>noreply@blogger.com (Thiago)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/Z0kjWwSLmKk" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/11/intel-releases-its-own-text-reader-for.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-1733890281129283577</guid><pubDate>Tue, 10 Nov 2009 18:17:00 +0000</pubDate><atom:updated>2009-11-10T13:30:22.448-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">blog community</category><category domain="http://www.blogger.com/atom/ns#">Healthcare reform</category><category domain="http://www.blogger.com/atom/ns#">Healthcare innovation</category><category domain="http://www.blogger.com/atom/ns#">Pharma and Social Media</category><category domain="http://www.blogger.com/atom/ns#">AstraZeneca</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">AZ Health Connections</category><category domain="http://www.blogger.com/atom/ns#">Online technologies</category><title>AstraZeneca is joining the conversation</title><atom:summary>In a recent article at Delaware Online, the reveal how and why AstraZeneca is jumping into the social media conversation.  Earl Whipple, the Senior Director of AstraZeneca's Corporate Communications Group, is the senior editor of the AZ Health Connections blog, has used the blog to communicate about a variety of topics, including healthcare reform, innovation, and the current state of Pharma and </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/PsQZoApQeqE/astrazeneca-is-joining-conversation.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/PsQZoApQeqE" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/11/astrazeneca-is-joining-conversation.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-2430305982362713752</guid><pubDate>Wed, 04 Nov 2009 18:11:00 +0000</pubDate><atom:updated>2009-11-04T13:14:24.931-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">online community</category><category domain="http://www.blogger.com/atom/ns#">NovoNordisk</category><category domain="http://www.blogger.com/atom/ns#">epharma 2010</category><category domain="http://www.blogger.com/atom/ns#">social network pharma</category><category domain="http://www.blogger.com/atom/ns#">epharma news</category><category domain="http://www.blogger.com/atom/ns#">hemophilia</category><title>Novo Nordisk re-launches hemophilia campaign</title><atom:summary>Evelyn Lee of NJBiz.com reports that New Jersey-based pharmaceutical company, Novo Nordisk has relaunched it's hemophilia campaign. Its “changing possibilities in hemophilia” campaign with a re-branded Web site and a new community on the social networking site Facebook. The new online resources are intended to reach the hemophilia inhibitor community, which represents just 800 to 900 Americans, </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/TEChFBmRhYA/novo-nordisk-re-launches-hemophilia.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/TEChFBmRhYA" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/11/novo-nordisk-re-launches-hemophilia.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-2860549914178732194</guid><pubDate>Fri, 30 Oct 2009 16:23:00 +0000</pubDate><atom:updated>2009-10-30T12:27:56.908-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">dm news</category><category domain="http://www.blogger.com/atom/ns#">big pharma news</category><category domain="http://www.blogger.com/atom/ns#">pharma social media</category><category domain="http://www.blogger.com/atom/ns#">social media news</category><title>Agencies partner to launch social media service for pharma companies</title><atom:summary>Cara Wood of DMNews.com writes, Extrovertic and Virilion announced a joint venture on October 28, called EV Healthcare, to help healthcare companies implement digital and social media marketing campaigns. The service, based in New York, has just begun marketing to prospective clients, saidPfizer veteran Dorothy Wetzel, co-founder and executive marketer at Extrovertic.“When there's a lot of change</atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/Z0VlZWYUzqQ/agencies-partner-to-launch-social-media.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/Z0VlZWYUzqQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/agencies-partner-to-launch-social-media.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-5736124881955728935</guid><pubDate>Thu, 29 Oct 2009 13:06:00 +0000</pubDate><atom:updated>2009-10-29T09:09:01.852-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">web seminar</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">2010 ePharma summit</category><category domain="http://www.blogger.com/atom/ns#">Heartbeat Digital</category><title>Archived Webinar: Shifting Media, Shifting Minds – Optimize Online Engagement</title><atom:summary>If you missed your chance to view yesterday's live web seminar presented by Bill Drummy, the CEO of Heartbeat Digital, here's your chance to view it at your own leisure! Take some time to view the hour long webinar below. Enjoy!https://www1.gotomeeting.com/register/367946673</atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/bWaiDOwmudc/archived-webinar-shifting-media.html</link><author>noreply@blogger.com (ymmartin)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/bWaiDOwmudc" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/archived-webinar-shifting-media.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-515179614348467857</guid><pubDate>Tue, 27 Oct 2009 14:04:00 +0000</pubDate><atom:updated>2009-10-27T10:08:15.678-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">webinar epharma</category><category domain="http://www.blogger.com/atom/ns#">webinar social media</category><category domain="http://www.blogger.com/atom/ns#">pharma social media webinar</category><category domain="http://www.blogger.com/atom/ns#">webinar news</category><category domain="http://www.blogger.com/atom/ns#">complimentary webinar</category><title>Complimentary Webinar: Shifting Media, Shifting Minds – Optimize Online Engagement</title><atom:summary>Join us for a Webinar on Wednesday, October 282-3PM ESTSpace is limited.Reserve your Webinar seat now at:https://www1.gotomeeting.com/register/367946673Mention Priority Code: P1506LinkedInBLOGAbout the web seminar: The days of one-way brand communication (i.e. advertising) are over.  Engagement, utility and brand evangelism are the secrets to success in the user-controlled world of Facebook and </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/nD-DFGZ_XVY/complimentary-webinar-shifting-media.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/nD-DFGZ_XVY" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/complimentary-webinar-shifting-media.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-3671974623931838043</guid><pubDate>Thu, 22 Oct 2009 17:46:00 +0000</pubDate><atom:updated>2009-10-22T13:51:27.209-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">emerging technologies</category><category domain="http://www.blogger.com/atom/ns#">Chris Anderson</category><category domain="http://www.blogger.com/atom/ns#">Wired Magazine</category><category domain="http://www.blogger.com/atom/ns#">personalized medicine</category><category domain="http://www.blogger.com/atom/ns#">Minibuster</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Chris Anderson, Editor in Chief of Wired magazine will be at ePharma 2010!</title><atom:summary>Chris Anderson, Editor in Chief of Wired magazine, will be a keynote presenterat the ePharma Summit in February 2010Are you interested in How Emerging Technologies Will Impact Consumer Behavior &amp; Preferences? If the answer is yes, be sure to join us on the morning of Wednesday, February 10th at 8:15 at the ePharma Summit 2010, where Chris Anderson will discuss the long tail of the pharmaceutical </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/G1rz7RKuqnk/chris-anderson-editor-in-chief-of-wired.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/G1rz7RKuqnk" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/chris-anderson-editor-in-chief-of-wired.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-6811578658225316189</guid><pubDate>Wed, 21 Oct 2009 18:21:00 +0000</pubDate><atom:updated>2009-10-21T14:23:51.523-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">epharma 2010</category><category domain="http://www.blogger.com/atom/ns#">epharma news</category><category domain="http://www.blogger.com/atom/ns#">pharma social media</category><category domain="http://www.blogger.com/atom/ns#">epharma social media</category><category domain="http://www.blogger.com/atom/ns#">social media news</category><title>Widget Wonderland at FDA-Who Knew?</title><atom:summary>Angie Drakulich of PharmTech News writes today that the FDA will hold its public meeting to discuss the use of social media tools in marketing pharmaceutical drug products. The last time the agency held a meeting to discuss these types of items was in 1996 when the Internet’s popularity was growing by leaps and bounds. While the agency is doing its best to figure out how to regulate online </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/GqCUwiNGCic/widget-wonderland-at-fda-who-knew.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/GqCUwiNGCic" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/widget-wonderland-at-fda-who-knew.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-5118781902077819460</guid><pubDate>Thu, 15 Oct 2009 20:50:00 +0000</pubDate><atom:updated>2009-10-15T16:54:59.442-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Obama administration</category><category domain="http://www.blogger.com/atom/ns#">David Blumenthal</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Digital health records</category><category domain="http://www.blogger.com/atom/ns#">Adopting digital health records</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Dr. David Blumenthal's view on medical records</title><atom:summary>The New York Times recently had a piece where Dr. David Blumenthal, an adviser for President Obama on digitizing health records, spoke about what the current situation is for transition to digitized medical records and what the benefits will be when US doctors fully move over to the system.  This includes patients being able to better manage their care and doctors and hospitals performing at </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/nsCMrkEEIsg/dr-david-blumenthals-view-on-medical.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/nsCMrkEEIsg" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/dr-david-blumenthals-view-on-medical.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-1767630507850682621</guid><pubDate>Wed, 14 Oct 2009 13:36:00 +0000</pubDate><atom:updated>2009-10-14T09:40:55.464-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">medicaid blog</category><category domain="http://www.blogger.com/atom/ns#">medicaid news</category><category domain="http://www.blogger.com/atom/ns#">mdrp</category><category domain="http://www.blogger.com/atom/ns#">webinar news</category><category domain="http://www.blogger.com/atom/ns#">epharma blog</category><category domain="http://www.blogger.com/atom/ns#">webinars</category><title>Free Webinar Tomorrow: Overcoming the Challenges of Government Pricing, Compliance Reporting and Medicaid Rebate Processing</title><atom:summary>October 15, 20092-3PM ESTSpace is limited.Reserve your Webinar seat now at: https://www1.gotomeeting.com/register/286708561Priority code: P1458W1BLOG/TWITTERAbout the web seminar:All pharmaceutical product manufacturers who sell to various agencies of the federal government and/or who participate in Medicaid, 340B, Medicare or other public sector reimbursement programs face significant </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/RLTSzbKHDHY/free-webinar-tomorrow-overcoming.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/RLTSzbKHDHY" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/free-webinar-tomorrow-overcoming.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-8208512434808509761</guid><pubDate>Fri, 09 Oct 2009 18:31:00 +0000</pubDate><atom:updated>2009-10-09T14:37:02.841-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Facebook</category><category domain="http://www.blogger.com/atom/ns#">web seminar</category><category domain="http://www.blogger.com/atom/ns#">Twitter</category><category domain="http://www.blogger.com/atom/ns#">2010 ePharma summit</category><category domain="http://www.blogger.com/atom/ns#">Heartbeat Digital</category><category domain="http://www.blogger.com/atom/ns#">Brand evangelism</category><category domain="http://www.blogger.com/atom/ns#">Bill Drummy</category><title>Complimentary Web Seminar: Shifting Media, Shifting Minds</title><atom:summary>Title:  Shifting Media, Shifting MindsDate:  Wednesday, October 28, 2009Time:  2:00 PM - 3:00 PM EDTRegister here: https://www1.gotomeeting.com/register/367946673Mention Priority code: P1506LinkedInBlogAbout the web seminar:The days of one-way brand communication (i.e. advertising) are over.  Engagement, utility and brand evangelism are the secrets to success in the user-controlled world of </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/3Og1rPl9mrw/complimentary-web-seminar-shifting.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/3Og1rPl9mrw" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/complimentary-web-seminar-shifting.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-6519185221620227634</guid><pubDate>Thu, 08 Oct 2009 13:59:00 +0000</pubDate><atom:updated>2009-10-08T10:03:02.743-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">pharma search engines</category><category domain="http://www.blogger.com/atom/ns#">pharma blogs</category><category domain="http://www.blogger.com/atom/ns#">fda warnings</category><category domain="http://www.blogger.com/atom/ns#">big pharma news</category><category domain="http://www.blogger.com/atom/ns#">pharma social media</category><title>Pharma Drops Search Advertising After FDA Warning</title><atom:summary>Fearing any further warnings or issues from the FDA, Pharma companies have dropped search advertising on search engines. AdAge reports that according to a study from web metrics measurement firm ComScore, paid search ads by pharmaceutical companies dropped a whopping 84% between March 26 of this year and the end of June. Pharma companies that believed they were in compliance with the unwritten "</atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/ASXF3_LWyUU/pharma-drops-search-advertising-after.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/ASXF3_LWyUU" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/pharma-drops-search-advertising-after.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-5135691068919077389</guid><pubDate>Tue, 06 Oct 2009 14:07:00 +0000</pubDate><atom:updated>2009-10-06T10:07:00.262-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">pharma marketing</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Online brand promotion for pharma</category><category domain="http://www.blogger.com/atom/ns#">Social media with physicians</category><category domain="http://www.blogger.com/atom/ns#">Pharma marketing channels</category><category domain="http://www.blogger.com/atom/ns#">ePharma 2009</category><title>New Multi-Marketing Channel Strategies for Pharma</title><atom:summary>The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited. Datamonitor’s </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/TPExYF5sNhs/new-multi-marketing-channel-strategies.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/TPExYF5sNhs" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/new-multi-marketing-channel-strategies.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-7151515130564730567</guid><pubDate>Fri, 02 Oct 2009 18:43:00 +0000</pubDate><atom:updated>2009-10-02T14:45:53.024-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">FDA social media guidelines</category><category domain="http://www.blogger.com/atom/ns#">epharma news</category><category domain="http://www.blogger.com/atom/ns#">pharma social media</category><category domain="http://www.blogger.com/atom/ns#">FDA guidelines</category><category domain="http://www.blogger.com/atom/ns#">social media news</category><title>FDA To Hold Hearings On Social-Media Use By Drug Makers</title><atom:summary>Mediapost.com reports that pharmaceutical companies in a quandary about what they can and cannot do on Web 2.0 are welcoming news that the Food and Drug Administration will hold a two-day public hearing on the issue Nov. 12-13 in Washington, Rich Thomaselli reports. Ad agencies that specialize in health-care marketing say the hearings, and any resulting guidelines, will be helpful for the </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/3jFQKJshbLo/fda-to-hold-hearings-on-social-media.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/3jFQKJshbLo" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/fda-to-hold-hearings-on-social-media.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-2373642834095789857</guid><pubDate>Thu, 01 Oct 2009 16:53:00 +0000</pubDate><atom:updated>2009-10-01T12:58:37.177-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Vaccines results</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">My Health Info</category><category domain="http://www.blogger.com/atom/ns#">High blood pressure monitoring</category><category domain="http://www.blogger.com/atom/ns#">Channel Web</category><category domain="http://www.blogger.com/atom/ns#">Online medical records</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Microsoft releases My Heatlh Info</title><atom:summary>According to Channel Web, Microsoft has released it's version of online medical records, My Health Info, to the public.  It's beta version is now online for individuals to begin managing their healthcare information, from high blood pressure to coordinating the medication they're using.  It also has an area for vaccines records as well as lab results.  Read about the new release here.What </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/TBaltQIRkWA/microsoft-releases-my-heatlh-info.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/TBaltQIRkWA" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/10/microsoft-releases-my-heatlh-info.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-5257829545867050406</guid><pubDate>Wed, 30 Sep 2009 18:52:00 +0000</pubDate><atom:updated>2009-09-30T14:57:40.481-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Chris Anderson</category><category domain="http://www.blogger.com/atom/ns#">Kevin Nalty</category><category domain="http://www.blogger.com/atom/ns#">Digital Marketing for Pharma</category><category domain="http://www.blogger.com/atom/ns#">2010 ePharma summit</category><category domain="http://www.blogger.com/atom/ns#">Shwen Gwee</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Registration open for ePharma Summit the most innovative digital marketing event for Pharma</title><atom:summary>The 9th Annual ePharma Summit is the most innovative digital marketing event for pharma. Year after year, hundreds of marketing professionals from leading pharmaceutical companies attend ePharma for incomparable access to insider information for optimizing their brand strategy and perfecting consumer relationships.Based on feedback from hundreds of pharmaceutical digital marketers and brand </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/dsmTkKG1kLI/registration-open-for-epharma-summit.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/dsmTkKG1kLI" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/registration-open-for-epharma-summit.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-2612098285569446016</guid><pubDate>Mon, 28 Sep 2009 19:15:00 +0000</pubDate><atom:updated>2009-09-28T15:26:21.153-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">North Shore Long Island Jewish Health System</category><category domain="http://www.blogger.com/atom/ns#">digitizing health records</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Regional health care groups</category><category domain="http://www.blogger.com/atom/ns#">Electronic health records</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Electronic records adopted by New York Hosptial</title><atom:summary>North Shore-Long Island Jewish Health System, a New York regional health care group, has announced the adoption of electronic records throughout it's system ranging from large hospitals to its doctors.  It will cost a total of $400 million to digitize the health records, but will more tightly link the doctors and hospitals together, along with labs to coordinate patient care, reduce medical </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/ADxOANOZ6lo/electronic-records-adopted-by-new-york.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/ADxOANOZ6lo" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/electronic-records-adopted-by-new-york.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-3202413521291901089</guid><pubDate>Wed, 23 Sep 2009 15:59:00 +0000</pubDate><atom:updated>2009-09-23T12:08:13.499-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Online behavior and medical students</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Patient doctor relationship</category><category domain="http://www.blogger.com/atom/ns#">medical students online</category><category domain="http://www.blogger.com/atom/ns#">Medical students</category><category domain="http://www.blogger.com/atom/ns#">patient doctor confidentially</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Future doctors and their current online lives</title><atom:summary>With new social lives taking place online, many professionals have found conflict between their personal profiles and how it affects their personal lives.  This is no different for future doctors, meaning that many medical students are also guilty of putting inappropriate content online.  Some situations are even violating doctor/patient confidentially. Of the Student Affairs offices interviewed,</atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/FGBrrYvDcFU/future-doctors-and-their-current-online.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/FGBrrYvDcFU" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/future-doctors-and-their-current-online.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-4306858366056692491</guid><pubDate>Fri, 18 Sep 2009 16:17:00 +0000</pubDate><atom:updated>2009-09-18T12:23:33.423-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Health care</category><category domain="http://www.blogger.com/atom/ns#">Pharmaceuticals online</category><category domain="http://www.blogger.com/atom/ns#">Growing resistance of antibiotics</category><category domain="http://www.blogger.com/atom/ns#">Online health</category><category domain="http://www.blogger.com/atom/ns#">Reuters</category><category domain="http://www.blogger.com/atom/ns#">online pharmacies</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>Online perscriptions present growing problem</title><atom:summary>As the nation moves to online health care, a separate issue is arising in terms of healthcare on the internet.  According to Reuters, there's a growing number of online websites that will provide prescription drugs with no questions asked.  The main concern to this practice is, in many cases, patients are taking the wrong drugs after self-prescribing the medication themselves.  This is </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/R7IqRipWckY/online-perscriptions-present-growing.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/R7IqRipWckY" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/online-perscriptions-present-growing.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-3021284483575364182</guid><pubDate>Tue, 15 Sep 2009 18:40:00 +0000</pubDate><atom:updated>2009-09-15T14:44:27.391-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CDC on Facebook</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Jay Bernhardt</category><category domain="http://www.blogger.com/atom/ns#">H1n1 Social Media</category><category domain="http://www.blogger.com/atom/ns#">CDC and Social Media</category><category domain="http://www.blogger.com/atom/ns#">H1N1 Virus</category><category domain="http://www.blogger.com/atom/ns#">CDC on Twitter</category><category domain="http://www.blogger.com/atom/ns#">Independent Florida Alligator</category><category domain="http://www.blogger.com/atom/ns#">CDC</category><title>CDC uses social media to distribute health incformation</title><atom:summary>According to the Independent Florida Alligator, the CDC will now be using Facebook and Twitter to help distribute information about the Swine Flu.Jay M. Bernhardt, director of the National Center for Health Marketing at the CDC stated"We have great information, [but] we have a terrible time distributing it.  It's about providing health information and interventions when, where, and how people </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/gjE7_VBeEzU/cdc-uses-social-media-to-distribute.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/gjE7_VBeEzU" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/cdc-uses-social-media-to-distribute.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-292794767554494716</guid><pubDate>Thu, 10 Sep 2009 20:12:00 +0000</pubDate><atom:updated>2009-09-10T16:17:55.837-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">AIDS treatments</category><category domain="http://www.blogger.com/atom/ns#">Widgets for doctors</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">AIDS treatment</category><category domain="http://www.blogger.com/atom/ns#">News widgets</category><category domain="http://www.blogger.com/atom/ns#">New York State Health Department</category><category domain="http://www.blogger.com/atom/ns#">Healthcare widgets</category><category domain="http://www.blogger.com/atom/ns#">ePharma</category><title>New widget helps NY doctors treat AIDS</title><atom:summary>According to NY1, a new widget introduced by the New York State Health Department will help doctors know the latest medical information for treating patients with HIV and AIDS.  This widget will provide doctors with podcasts, a hotline and email that will be constantly updated with the latest news on how to treat patients with the disease.  Click here to watch the news report.This is a great way </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/hF8f3wyI_Rw/new-widget-helps-ny-doctors-treat-aids.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/hF8f3wyI_Rw" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/new-widget-helps-ny-doctors-treat-aids.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-2562735432932979544</guid><pubDate>Wed, 09 Sep 2009 16:14:00 +0000</pubDate><atom:updated>2009-09-09T12:20:13.795-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">epharma updates</category><category domain="http://www.blogger.com/atom/ns#">epharma news</category><category domain="http://www.blogger.com/atom/ns#">social media news</category><category domain="http://www.blogger.com/atom/ns#">anthem health</category><category domain="http://www.blogger.com/atom/ns#">social media pharma</category><category domain="http://www.blogger.com/atom/ns#">anthem health social media</category><title>Anthem Blue Cross and Blue Shield in Wisconsin Harnesses Social Media to Interact with Members</title><atom:summary>In an effort to connect with customers, Anthem Blue Cross and Blue Sheild of Wisconsin has begun to utilize social media. According to Reuters, the healthcare insurance giant is piloting a program in which it uses Twitter to identify members who may have questions or concerns about their health benefits. Twitter allows Anthem to communicate and stay connected through the exchange of quick, real </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/YelejkjV_7c/anthem-blue-cross-and-blue-shield-in.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/YelejkjV_7c" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/anthem-blue-cross-and-blue-shield-in.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1503474135064942707.post-5670357753734532942</guid><pubDate>Tue, 08 Sep 2009 20:27:00 +0000</pubDate><atom:updated>2009-09-08T16:46:38.202-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">pharma marketing</category><category domain="http://www.blogger.com/atom/ns#">FDA</category><category domain="http://www.blogger.com/atom/ns#">ePharma Summit</category><category domain="http://www.blogger.com/atom/ns#">Online pharma advertising</category><category domain="http://www.blogger.com/atom/ns#">2010 ePharma summit</category><category domain="http://www.blogger.com/atom/ns#">FTC</category><title>A Glimpse at a World Without Rules in Pharma Marketing</title><atom:summary>Jonathan Richman recently posted on the imedia connection blog what would happen if there was no FDA, FTC, or DDMAC to set guidelines and rules for marketers in pharma. At first it seems like a great idea but then he went on to explain that instead of the FDA critiquing and reviewing your products it would instead be the patients, doctors, caregivers, researchers, payors, random pharma  critics, </atom:summary><link>http://feedproxy.google.com/~r/ePharmaSummit/~3/IKzN4Uez9ag/glimpse-at-world-without-rules-in.html</link><author>noreply@blogger.com (Thiago)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">2</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/ePharmaSummit/~4/IKzN4Uez9ag" height="1" width="1"/&gt;</description><feedburner:origLink>http://epharmasummit.blogspot.com/2009/09/glimpse-at-world-without-rules-in.html</feedburner:origLink></item></channel></rss>
